Publications by authors named "J F Marier"

Claim this Profile
U
Use of PopPK and E-R Analyses toward Explaining Causal Link Between ADAMTS13 in Recombinant vs. Plasma-Based Therapies and Clinical Effects in cTTP.
Munjal Patel, Huijuan Xu, Olivier Barriere, Paul Diderichsen, Parth Patwari, Jean François Marier

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo variant analysis of childhood-onset obsessive-compulsive disorder in the French-Canadian population.
Kate Bornais, Jay P Ross, Zoe Schmilovich, Miranda Medeiros, Charles-Étienne Castonguay, Jean-Jacques Marier

Transl Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic and exposure-response analysis to support a dosing regimen of CPX-351 (NS-87) in Japanese adult and pediatric patients with untreated high-risk acute myeloid leukemia.
Shunji Imai, Ayane Kitada, Aya Ogura, Michiyo Akagi, Mayumi Hasegawa, J F Marier

Drug Metab Pharmacokinet· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentration-QTc modeling of sitravatinib in patients with advanced solid malignancies.
Adam Dickinson, Yong Liu, Artem Uvarov, Thomas Peyret, J F Marier

Clin Transl Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD.
Frank W G Leebeek, Giancarlo Castaman, Jean François Marier, Gülden Özen, Indranil Bhattacharya

TH Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis